Taylor Swift's familial connection to Emily Dickinson stirs renewed interest in poet
Swift’s albums and their thematic parallels to Dickinson’s works have fueled speculations about the contemporary relevance of the poet
By Vibhuti PathakMar 06, 2024
Emily Dickinson, often regarded as the "patron saint of the shy," is entrenched in a cultural myth that paints her as a reclusive figure, clad in white, who wrote poetry in seclusion.
However, recent connections between Dickinson and pop sensation Taylor Swift, claiming them to be sixth cousins, three times removed, have stirred renewed interest in the 19th-century poet.
Swift's albums, particularly Evermore, with its release date coinciding with Dickinson's birthday and thematic parallels to Dickinson's works, have fueled speculations about the contemporary relevance of the poet.
"If my lyrics sound like a letter written by Emily Dickinson's great-grandmother while sewing a lace curtain, that's me writing in the quill genre," said Swift while accepting the Songwriter-Artist of the Decade award from the Nashville Songwriters Association International in 2022. That quote draws on associations with the 19th-Century poet that have long lingered since she died in 1886.
The pervasive image of Dickinson as a solitary figure, reluctant to leave her bedroom, has contributed to a cult-like fascination surrounding her. This persona, often dubbed the "patron saint of shy persons," emerged despite Dickinson's actual social engagement and intellectual prowess.
The 2017 film A Quiet Passion and Rosanna Bruno's graphic novel, The Slanted Life of Emily Dickinson, have sought to challenge and diversify this narrow perception.
A Quiet Passion is a 2016 British biographical film about the life of American poet Emily Dickinson, which stars Cynthia Nixon as the reclusive poet. (Photo credit: iStock)
A Quiet Passion
Dickinson, who wrote nearly 1,800 poems, faced limited publication during her lifetime, with only ten poems printed before she died in 1886. Posthumously, her work gained a devoted fan base, particularly among women readers, leading to pilgrimages to her home, the Homestead, now a museum in Amherst, Massachusetts.
The allure of Dickinson's poetry lies in its exploration of themes such as love, desire, pain, and death, considered unconventional for a 19th-century writer.
The myth of Dickinson as a reclusive spinster, isolated from the world, has been perpetuated for decades. This image, juxtaposed with the reality of Dickinson's social activism, forms a paradox that captivates readers and scholars alike. While Dickinson did retreat from society, especially later in life, it was a deliberate choice that allowed her the freedom to address taboo topics openly.
In a staunchly patriarchal society, Dickinson's seclusion became a space for her to express ideas about love and desire that other writers of her time could not.
The 2018 film Wild Nights with Emily challenges the traditional narrative surrounding Dickinson. It portrays the poet as a passionate rebel, engaged in meaningful relationships and actively involved in the social dynamics of her time. Molly Shannon, known for her lively performances, plays Dickinson in this film, capturing the audacity and subversiveness of the poet's character.
Beyond the cinematic portrayal, Dickinson's own words offer insight into her extraordinary mind. Her poems, only ten published during her lifetime, reveal a profound understanding of the human experience.
A quote from one of her letters encapsulates the impact of her poetry: "If I feel physically as if the top of my head were taken off, I know that is poetry." This visceral connection to her work underscores the depth and audacity with which Dickinson approached her craft.
Despite Dickinson's complexity and the ongoing efforts to dispel myths, her legacy endures. Scholars like Paul Hetherington emphasize her role as the first truly modern poet in the English language, challenging societal norms and conventions.
The reevaluation of Dickinson's life and work extends beyond her poetry to address the marketing and construction of her public image, highlighting the potential disconnect between an artist's persona and the true meaning of their work.
In conclusion, Emily Dickinson's mystique as the "patron saint of the shy" has perpetuated a narrow and often inaccurate view of her life and poetry. Recent connections to contemporary figures like Taylor Swift and creative projects like Wild Nights with Emily and The Slanted Life of Emily Dickinson strive to present a more nuanced and authentic portrayal.
Dickinson's poems, timeless in their audacity and modernity, continue to resonate and inspire, challenging readers to reassess the cultural myths surrounding this iconic poet.
UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.
Investment gap
Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.
Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.
Richard Torbett, ABPI Chief Executive, noted “The UK can lead globally in medicines and vaccines, unlocking billions in R&D investment and improving patient access but only if barriers are removed and innovation rewarded.”
The UK invests just 9% of healthcare spending in medicines, compared with 17% in Spain, and only 37% of new medicines are made fully available for their licensed indications, compared to 90% in Germany.
Expert reviews
Shailesh Solanki, executive editor of Pharmacy Business, pointed that “The government’s own review shows the sector is underfunded by about £2 billion per year. To make transformation a reality, this gap must be closed with clear plans for investment in people, premises and technology.”
The National Institute for Health and Care Excellence (NICE) cost-effectiveness threshold £20,000 to £30,000 per Quality-Adjusted Life Year (QALY) — has remained unchanged for over two decades, delaying or deterring new medicine launches. Raising it is viewed as vital to attracting foreign investment, expanding patient access, and maintaining the UK’s global standing in life sciences.
Guy Oliver, General Manager for Bristol Myers Squibb UK and Ireland, noted that " the current VPAG rate is leaving UK patients behind other countries, forcing cuts to NHS partnerships, clinical trials, and workforce despite government growth ambitions".
Reeves’ push for reform, supported by the ABPI’s Competitiveness Framework, underlines Britain’s intent to stay a leading hub for pharmaceutical innovation while ensuring NHS patients will gain faster access to new treatments.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.